This is the second in a series of blog posts focused on AI and clinical trials/research space, highlighting topics to be discussed at the upcoming BIO International convention on June 22-25, 2026.
Introduction
Your latest trial sponsor is using AI to accelerate protocol development and patient recruitment,[1] cutting timelines that once took months
On May 13, the Centers for Medicare & Medicaid Services (CMS) announced a nationwide enrollment moratorium on new Medicare hospice and home health agency (HHA) participants. The announcement follows the introduction of Rhode Island House Bill 8214 in February 2026, which, if enacted, would freeze new state licensure for home care, home nursing care, and
Register for our webinar, AI in Your Organization: Are Your Contracts Keeping Up?, on May 19 at noon CT, presented by Kris Kappel and Maggie Mannebach.
Artificial intelligence is no longer an emerging technology—it is embedded in the mainstream enterprise software, platforms, and vendor services that organizations rely on every day. In many cases,
A Final Rule updating Section 504 of the Rehabilitation Act of 1973 recently published by the Department of Health and Human Services (HHS) issued new mandates stipulating that every facility, program, or activity with 15 or more employees that receives HHS funding will need to comply with new digital accessibility guidelines.
To align its requirements
On April 24, 2024, the Department of Justice (DOJ) published a final rule to adopt the Web Content Accessibility Guidelines, version 2.1 Level AA (WCAG 2.1) as the compliance standard for web and mobile app accessibility for Title II entities under the Americans with Disabilities Act (ADA).
After our recent presentation, Physician Owner Mindset, Compliance Guardrails: Growth Without the Gotchas, at the American Alliance of Orthopaedic Executives on April 21, we wanted to share some practical insights on incentive design, deal structure, and how these issues surface in transactions and enforcement—key topics we touched on in our discussion. We think you will
This is the first in a series of blog posts focused on AI and clinical trials/research space, highlighting topics to be discussed at the upcoming BIO International convention on June 22-25, 2026.
A major research institution combines 15 years of patient genomic data with metabolomic profiles and clinical outcomes, feeding it into an AI model
On April 1, 2026, Governor Bill Lee signed Senate Bill 1580 into law, making Tennessee among the first states to specifically regulate how AI can be marketed and used in the mental health space. The new law takes effect July 1, 2026.
This is the sixth and final installment in a six-part series on incentive design, deal structure, and how these issues surface in transactions and enforcement. Other relevant topics will be discussed in our upcoming presentation, Physician Owner Mindset, Compliance Guardrails: Growth Without the Gotchas, to be given at the American Alliance of Orthopaedic Executives on
This is the fifth in a six-part series on incentive design, deal structure, and how these issues surface in transactions and enforcement. Other relevant topics will be discussed in our upcoming presentation, Physician Owner Mindset, Compliance Guardrails: Growth Without the Gotchas, to be given at the American Alliance of Orthopaedic Executives on Tuesday, April 21.
